GlassScriptPhysician profile
Zantha C Marcuson
NPI 1174626600
$1,331.32
in general payments reported to CMS, 2019-2025
16 companies · $441 in 2025
The $441 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $88.18 · 2021: $82.95 · 2022: $92.55 · 2023: $258 · 2024: $246 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $202.95 | 2020-2024 | Otezla, Enbrel |
| Sun Pharmaceutical Industries INC. | $167.19 | 2021-2025 | Blu-U, Odomzo |
| Janssen Biotech, INC. | $160.00 | 2023-2025 | Tremfya |
| Abbvie INC. | $159.02 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $130.52 | 2020-2025 | |
| Ucb, INC. | $92.79 | 2024-2025 | Bimzelx |
| Verrica Pharmaceuticals INC. | $78.81 | 2023 | Ycanth |
| Leo Pharma INC. | $70.37 | 2019-2025 | Adbry |
| Genzyme Corporation | $58.11 | 2023-2025 | |
| Organogenesis INC. | $45.99 | 2025 | Simplimax |
| Almirall LLC | $45.44 | 2021 | |
| Pfizer INC. | $35.44 | 2020-2025 | |
| Incyte Corporation | $28.49 | 2025 | Opzelura |
| Biofrontera INC. | $21.97 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $19.29 | 2023 | Libtayo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $14.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zantha Marcuson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.